Determinants of Self-reported Health Outcomes in Adrenal Insufficiency: A Multisite Survey Study

J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1408-e1419. doi: 10.1210/clinem/dgaa668.

Abstract

Context: Current evidence on determinants of adverse health outcomes in patients with adrenal insufficiency (AI) is scarce, especially in regards to AI subtypes.

Objective: To determine predictors of adverse outcomes in different subtypes of AI.

Design and setting: Cross-sectional survey study at 2 tertiary centers.

Participants: A total of 696 patients with AI: primary AI (PAI, 42%), secondary AI (SAI, 32%), and glucocorticoid-induced AI (GIAI, 26%).

Intervention: Patient-centered questionnaire.

Main outcome measures: Patients' knowledge, self-management of AI, self-perceived health, and adverse outcomes.

Results: The incidence rate of adrenal crisis was 24/100 patient-years with 44% experiencing at least 1 adrenal crisis since diagnosis (59% in PAI vs 31% in SAI vs 37% in GIAI, P < .0001). All patients described high degrees of discomfort with self-management and receiving prompt treatment. Patients with PAI were most likely to develop adrenal crises (adjusted OR 2.8, 95% CI 1.9-4.0) despite reporting better self-perceived health (adjusted OR 3.3, 95% CI 2.1-5.3), understanding of their diagnosis (89% vs 74-81% in other subtypes, P = .002), higher comfort with self-management (62% vs 52-61% in other sub types, P = .005), and higher likelihood to receive prompt treatment for adrenal crises in the emergency department (42% vs 19-30% in other subtypes, P < .0001).

Conclusions: Patients with AI reported high degrees of discomfort with self-management and treatment delays when presenting with adrenal crises. Despite better self-perceived health and understanding of diagnosis, patients with PAI experienced the highest frequency of adrenal crises. A multidimensional educational effort is needed for patients and providers to improve the outcomes of all subtypes of AI.

Keywords: adrenal crisis; diagnosis; glucocorticoid therapy; healthcare delivery; management.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adrenal Insufficiency / diagnosis*
  • Adrenal Insufficiency / epidemiology
  • Adrenal Insufficiency / pathology
  • Adrenal Insufficiency / therapy
  • Adult
  • Comorbidity
  • Cross-Sectional Studies
  • Disease Progression
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Patient Reported Outcome Measures*
  • Prognosis
  • Risk Factors
  • Self Report / statistics & numerical data
  • Surveys and Questionnaires
  • United States / epidemiology
  • Young Adult

Substances

  • Glucocorticoids